You have 9 free searches left this month | for more free features.

vandetanib

Showing 1 - 25 of 55

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory

Recruiting
  • Advanced Malignant Neoplasm
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Invasive Breast Cancer Trial in Iowa City (Vandetanib, Placebo)

Terminated
  • Invasive Breast Cancer
  • Vandetanib
  • Placebo
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 1, 2021

Medullary Thyroid Cancer Trial in Cordoba, Sevilla (Pralsetinib, Cabozantinib, Vandetanib)

Not yet recruiting
  • Medullary Thyroid Cancer
  • Cordoba, Spain
  • +1 more
Jan 11, 2023

Thyroid Tumors Trial in Worldwide (Vandetanib, Placebo)

Active, not recruiting
  • Thyroid Neoplasms
  • Vandetanib
  • Placebo
  • Brussels, Belgium
  • +21 more
Oct 20, 2021

Renal Cell Carcinoma, Hereditary Leiomyomatosis, Renal Cell Cancer Trial run by the NCI (Vandetanib, Metformin,

Terminated
  • Renal Cell Carcinoma
  • +2 more
  • Vandetanib
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 12, 2021

Non Small Cell Lung Cancer Trial in Seoul (Vandetanib)

Completed
  • Non Small Cell Lung Cancer
  • Vandetanib
  • Seoul, Korea, Republic of
  • +1 more
Dec 4, 2020

Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia Type 2A, Multiple Endocrine Neoplasia Type 2B Trial run by the NCI

Completed
  • Medullary Thyroid Carcinoma
  • +2 more
  • Vandetanib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 1, 2020

Locally Advanced or Metastatic Medullary Thyroid Cancer, Medullary Thyroid Cancer Trial in Worldwide (Patient outreach,

Active, not recruiting
  • Locally Advanced or Metastatic Medullary Thyroid Cancer
  • Medullary Thyroid Cancer
  • Patient outreach
  • Vandetanib
  • St Leonards, Australia
  • +33 more
Oct 20, 2021

Lip and Oral Cavity Squamous Cell Carcinoma, Oral Cavity Verrucous Carcinoma, Precancerous Condition Trial in Chicago (drug,

Completed
  • Lip and Oral Cavity Squamous Cell Carcinoma
  • +2 more
  • vandetanib
  • +5 more
  • Chicago, Illinois
    University of Chicago
Jan 8, 2021

Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)

Terminated
  • Thyroid Cancer
  • +5 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jul 12, 2021

Cancer of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Cancer of the Stomach Trial in Philadelphia

Completed
  • Cancer of the Esophagus
  • +2 more
  • Vandetanib
  • +4 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 4, 2021

GIST Trial run by the NCI (Vandetanib)

Completed
  • GIST
  • Vandetanib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 25, 2020

Cancer, High-grade Glioma Trial in Amsterdam (Sunitinib, vandetanib, Erlotinib)

Unknown status
  • Cancer
  • High-grade Glioma
  • Amsterdam, Noord-Holland, Netherlands
    VU University Medical Center
Oct 6, 2020

Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)

Active, not recruiting
  • Metastatic Breast Cancer
  • Angers, France
  • +24 more
Mar 8, 2022

NSCLC Metastatic Trial in France (AZD2014, AZD4547, AZD5363)

Active, not recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Avignon, France
  • +36 more
Jul 29, 2022

Non Small Cell Lung Cancer, Lung Cancer Trial in Worldwide (Vandetanib, Pemetrexed)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Lung Cancer
  • Casa Grande, Arizona
  • +109 more
Oct 20, 2021

Relapsed Pediatric Solid Tumor, Refractory Pediatric Solid Tumor, Relapsed Pediatric AML Trial in Seoul (CancerSCAN™,

Recruiting
  • Relapsed Pediatric Solid Tumor
  • +3 more
  • CancerSCAN™
  • +17 more
  • Seoul, Korea, Republic of
    Samsung Medical Center
Mar 18, 2020

Medullary Thyroid Cancer Trial in Worldwide (Selpercatinib, Cabozantinib, Vandetanib)

Recruiting
  • Medullary Thyroid Cancer
  • Birmingham, Alabama
  • +148 more
Jan 18, 2023

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Ureter Cancer Trial in United Kingdom (carboplatin,

Completed
  • Bladder Cancer
  • +3 more
  • Glasgow, Scotland, United Kingdom
  • +20 more
May 14, 2019

Medullary Thyroid Carcinoma Trial run by the NCI (Bortezomib, Vandetanib)

Terminated
  • Medullary Thyroid Carcinoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 5, 2018

Transitional Cell Carcinoma, Bladder Cancer Trial in Boston (Docetaxel, vandetanib, Placebo)

Completed
  • Transitional Cell Carcinoma
  • Bladder Cancer
  • Boston, Massachusetts
  • +2 more
Aug 20, 2018

Colorectal, Cancer Trial in Worldwide (Vandetanib, FOLFOX regimen=oxaliplatin, fluorouracil, & folinic acid)

Completed
  • Colorectal
  • Cancer
  • Vandetanib
  • FOLFOX regimen=oxaliplatin, fluorouracil, & folinic acid
  • Lille Cedex, France
  • +14 more
Jan 24, 2018

Medullary Thyroid Cancer Trial in Overland Park (vandetanib, omeprazole, ranitidine)

Completed
  • Medullary Thyroid Cancer
  • vandetanib
  • +2 more
  • Overland Park, Kansas
    Research Site
Apr 28, 2017

Breast Cancer, Head Neck Cancer, Lung Cancer Trial (drug, genetic, other)

Withdrawn
  • Breast Cancer
  • +4 more
  • (no location specified)
Apr 20, 2017

Breast Cancer Trial in Stanford (Vandetanib, Anastrozole)

Terminated
  • Breast Cancer
  • Stanford, California
    Stanford University School of Medicine
Dec 13, 2016